BackgroundCheck.run
Search For

David Chantry, 78PO Box 931, Idaho Springs, CO 80452

Related to:
Florence Zorgdrager Jack Vandenberg 94 Charles J Cogan 63 Earl T Cogan Venita J Vandenburg

David Chantry Phones & Addresses

Idaho Springs, CO   

Highlands Ranch, CO   

Grand Rapids, MI   

Katonah, NY   

Evergreen, CO   

South Salem, NY   

Davenport, IA   

Evergreen, CO   

Get Report
Control this profile

Mentions for David Chantry

David Chantry resumes & CV records

Resumes

David Chantry Photo 27

David Chantry

Skills:
Molecular Biology, Lifesciences, Drug Discovery, Cell Biology, Biotechnology, Immunology, Elisa, Cell, Assay Development, Cell Culture, Oncology, Life Sciences
David Chantry Photo 28

David Chantry

Publications & IP owners

Us Patents

Methods And Combination Therapy To Treat Cancer

US Patent:
2020036, Nov 26, 2020
Filed:
Jan 10, 2018
Appl. No.:
16/961133
Inventors:
- Boulder CO, US
David CHANTRY - Boulder CO, US
Shannon L. WINSKI - Boulder CO, US
International Classification:
A61K 31/4184
A61K 39/395
A61K 9/00
A61P 35/00
Abstract:
This invention relates to a method of treating cancer by administering to a patient in need thereof, over a period of time, therapeutic agents that consist essentially of a MEK inhibitor which is binimetinib or a pharmaceutically acceptable salt thereof, and a PD-1 binding antagonist, to a patient in need thereof.

Methods And Combination Therapy To Treat Cancer

US Patent:
2019021, Jul 18, 2019
Filed:
Jan 10, 2019
Appl. No.:
16/244768
Inventors:
- Boulder CO, US
David Chantry - Boulder CO, US
Shannon L. Winski - Boulder CO, US
International Classification:
A61K 39/395
A61P 35/00
A61K 31/4184
A61P 35/04
A61K 9/00
Abstract:
This invention relates to a method of treating cancer by administering to a patient in need thereof, over a period of time, therapeutic agents that consist essentially of a MEK inhibitor which is binimetinib or a pharmaceutically acceptable salt thereof, and a PD-1 binding antagonist, to a patient in need thereof.

Methods And Combination Therapy To Treat Cancer

US Patent:
2019021, Jul 11, 2019
Filed:
Jan 10, 2019
Appl. No.:
16/244827
Inventors:
- Boulder CO, US
David Chantry - Boulder CO, US
Shannon L. Winski - Boulder CO, US
International Classification:
C07K 16/28
A61P 35/04
A61K 9/00
A61K 31/4439
Abstract:
This invention relates to a method of treating cancer by administering a combination therapy comprising a combination of CSF-1R inhibitor, which is ARRY-382 or a pharmaceutically acceptable salt thereof, and a PD-1 binding antagonist, to a patient in need thereof.

Possible Relatives

John R Chantry  Margaret B Chantry  Julie Chantry  Karen A Chantry  Kelly Chantry  Linda M Chantry  Michael A Chantry  David Last  David W Johnson  David Stamps 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.